InflammaCalm IV™ is a curcumin-centered intravenous anti-inflammatory protocol designed to suppress NF-κB, STAT3, COX-2, and inflammatory cytokine signaling that contributes to tumor progression, treatment resistance, cancer-related pain, and fatigue.
